Zobrazeno 1 - 10
of 155
pro vyhledávání: '"Weiguo Su"'
Autor:
Shuwen Jiang, Xiangkun Li, Weifang Xue, Sumei Xia, Jian Wang, Yang Sai, Guangxiu Dai, Weiguo Su
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Amdizalisib, also named HMPL-689, a novel selective and potent PI3Kδ inhibitor, is currently under Phase II clinical development in China for treating hematological malignancies. The preclinical pharmacokinetics (PK) of amdizalisib were extensively
Externí odkaz:
https://doaj.org/article/171a0dd993234a97b37b3479bb05b230
Publikováno v:
Journal of Materials Research and Technology, Vol 24, Iss , Pp 5514-5525 (2023)
Carbon fiber reinforced polyamide-imide (CF/PAI) composites are potential candidates for high temperature applications under high stress conditions. However, the structure–property relationships of CF/PAI are not clear. This work presented an exper
Externí odkaz:
https://doaj.org/article/af0145e43c674655b095c2fedd7619a2
Autor:
Yuqin Song, Junning Cao, Qingyuan Zhang, Caixia Li, Lugui Qiu, Junyuan Qi, Huilai Zhang, Wenyu Li, Lihong Liu, Hongmei Jing, Keshu Zhou, Weijing Zhang, Liling Zhang, Daqi Li, Liqun Zou, Haiyan Yang, Wenbin Qian, Hui Zhou, Jianda Hu, Hongyan Yin, Sisi Fu, Songhua Fan, Qian Xu, Jian Wang, Xiaoyun Jia, Guangxiu Dai, Weiguo Su, Jun Zhu
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Sovleplenib (HMPL-523) is a selective spleen tyrosine kinase (Syk) inhibitor with antitumor activity in preclinical models of B-cell malignancy. We conducted a dose-escalation and dose-expansion phase I study of sovleplenib in patients with relapsed/
Externí odkaz:
https://doaj.org/article/2a631b479f3e41d4be020eef1b73030c
Autor:
Lijuan Hu, Wei-LI Zhao, Wen Wu, Xudong Wei, Ruihua MI, Yu Hu, Qiubai LI, Wenjuan He, Juan LI, Yugang Dong, Hehua Wang, Xuhan Zhang, Yu Zhang, Zhongyuan Xu, Hui Liu, Zhen Cai, Jie Sun, Yajing Xu, Zhiping Jiang, Cheng Zhang, Guo Chen, Tiejun Gong, Qinghua Tang, Hongmei Jing, Lan MA, Sujun Gao, Qiqi Liu, Zeyu Zhong, Yongxin Ren, Jian Chen, Songhua Fan, Michael Shi, Weiguo Su, Xiaojun Huang
Publikováno v:
HemaSphere, Vol 7, p e86312d3 (2023)
Externí odkaz:
https://doaj.org/article/ee9e9aa792c744dbbcafc05da152aad4
Publikováno v:
Regenerative Therapy, Vol 21, Iss , Pp 166-174 (2022)
Adipose-derived stem cells (ADSCs) are stem cells with multidirectional differentiation potential isolated from adipose tissue. They have the same immunomodulatory effect as bone marrow mesenchymal stem cells in wound repair and immune regulation as
Externí odkaz:
https://doaj.org/article/410e397802ac4408a4b878174319143f
Autor:
Yongfeng Yu, Yongxin Ren, Jian Fang, Lejie Cao, Zongan Liang, Qisen Guo, Sen Han, Zimei Ji, Ye Wang, Yulan Sun, Yuan Chen, Xingya Li, Hua Xu, Jianying Zhou, Liyan Jiang, Ying Cheng, Zhigang Han, Jianhua Shi, Gongyan Chen, Rui Ma, Yun Fan, Sanyuan Sun, Longxian Jiao, Xiaoyun Jia, Linfang Wang, Puhan Lu, Qian Xu, Xian Luo, Weiguo Su, Shun Lu
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Background: Savolitinib, a selective MET inhibitor, showed efficacy in patients with non-small cell lung cancer (NSCLC), including pulmonary sarcomatoid carcinoma (PSC), harbouring MET exon 14 skipping alteration ( MET ex14). Objective: To analyse po
Externí odkaz:
https://doaj.org/article/3b81ba5a12644cf3a33f4b7ac70cce97
Autor:
Shun Lu, MD, Jian Fang, MD, Xingya Li, MD, Lejie Cao, MD, Jianying Zhou, MD, Qisen Guo, MD, Zongan Liang, MD, Ying Cheng, MD, Liyan Jiang, MD, Nong Yang, MD, Zhigang Han, MD, Jianhua Shi, MD, Yuan Chen, MD, Hua Xu, MD, Helong Zhang, MD, Gongyan Chen, MD, Rui Ma, MD, Sanyuan Sun, MD, Yun Fan, MD, Songhua Fan, MD, Jie Yu, MD, Puhan Lu, PhD, Xian Luo, MS, Weiguo Su, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 10, Pp 100407- (2022)
Introduction: Savolitinib has been found to have encouraging antitumor activity and a favorable safety profile in Chinese patients with pulmonary sarcomatoid carcinoma and other NSCLCs with MET exon 14 skipping alterations (MET ex14 positive) at the
Externí odkaz:
https://doaj.org/article/a7ca95375de14255b657fbafab37ec69
Publikováno v:
Polymers, Vol 14, Iss 17, p 3618 (2022)
The mechanical properties of epoxy resin can be enhanced by adding nanofillers into its matrix. This study researches and compares the impacts of adding nanofillers with different dimensions, including two-dimensional boron nitride and zero-dimension
Externí odkaz:
https://doaj.org/article/b11c42feef484041a5b3b50f5736aea7
Autor:
Yu Cai, Jun Yu, Ping Ren, Jianlin He, Zhipeng Wu, Kun Xiao, Hong Jia, Jian Wang, Yang Sai, Guangxiu Dai, Xiong Li, Weiguo Su, Karen Ngo, Glenda Castro, Paul D. Acton, Wai‐Ping Fung‐Leung, James P. Edwards, Jennifer Venable, Tadimeti S. Rao
Publikováno v:
Pharmacology Research & Perspectives, Vol 8, Iss 1, Pp n/a-n/a (2020)
Abstract Phosphoinositide 3‐kinases, delta (PI3Kδ) and gamma (PI3Kγ) are enriched in immune cells and regulate the development and function of innate and adaptive immunity. Dual PI3Kδγ inhibitors are considered high value targets for their pote
Externí odkaz:
https://doaj.org/article/d35f0a94d6e5495fbd5b168fdf381dbd
Autor:
Rui-Hua Xu, Jin Li, Yuxian Bai, Jianming Xu, Tianshu Liu, Lin Shen, Liwei Wang, Hongming Pan, Junning Cao, Dongsheng Zhang, Songhua Fan, Ye Hua, Weiguo Su
Publikováno v:
Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-8 (2017)
Abstract Background To assess the efficacy and safety of fruquintinib, a vascular endothelial growth factor receptor (VEGFR) inhibitor, in metastatic colorectal cancer (mCRC) patients. Methods A phase Ib open-label study and phase II randomized, plac
Externí odkaz:
https://doaj.org/article/57e42dfa7f9345c3b8b023e8b4867529